DUBLIN, May 12, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Vascular Stent Market by Type, Product, Material, End User - Global Forecast to 2022" report to their offering.
The vascular stent market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021. The growth of this market is majorly driven by factors such as technological advancements in vascular stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population.
On the basis of product, the vascular stent market is segmented into coronary stents, peripheral stents, and EVAR stent grafts. Peripheral stents are further segmented into carotid stents, renal artery stents, femoral stents, iliac stents, and other peripheral stents. EVAR stent grafts are further segmented into abdominal aortic aneurysm and thoracic aortic aneurysm. The coronary stents segment accounted for the largest share of the vascular stent market in 2016. The large share of this segment can primarily be attributed to the rising incidence of coronary artery disease and technological advancements in coronary stents.
On the basis of type, the market is segmented into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment accounted for the largest share in 2016 primarily due to the advantages these stents offer over bare-metal stents, including lower risk of restenosis and other related complications.
On the basis of mode of delivery, the vascular stent market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents segment is estimated to register the highest growth during the forecast period due to the growing regulatory approvals for balloon-expandable stents and the increasing number of research activities focusing on improving the balloon-expandable stent technology.
- Abbott Laboratories
- B. Braun Melsungen Ag
- Biotronik Se & Co. Kg
- Boston Scientific Corporation
- C.R. Bard, Inc.
- Endologix, Inc.
- Jotec Gmbh
- Lombard Medical
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Microport Scientific Corporation
- Terumo Corporation
- Translumina Gmbh
- Vascular Concepts Limited
- W.L. Gore and Associates, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Vascular Stent Market, By Type
7 Vascular Stent Market, By Product
8 Vascular Stent Market, By Mode of Delivery
9 Vascular Stent Market, By Material
10 Vascular Stent Market, By End User
11 Vascular Stent Market, By Region
12 Competitive Landscape
13 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/7l24ks/vascular_stent
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vascular-stent-market-to-reach-1768-billion-by-2021---increasing-number-of-angioplasty-procedures---research-and-markets-300456661.html
SOURCE Research and Markets